DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Fermenta Biotech Limited — Outcome of Board Meeting

NSE 2 hrs ago·11 Aug 2026, 7:54 am

Fermenta Biotech

Fermenta Biotech Limited has announced its unaudited financial results for the quarter ended June 30, 2026. The company has submitted these standalone and consolidated figures to the stock exchange, providing an update on its performance during this period.

For investors, this disclosure is a key milestone, as it offers a transparent view of the company's current financial health. The results will help the market assess Fermenta's operational efficiency and its ability to meet its targets in the near term.

Investors should closely examine the earnings per share, net profit margins, and the year-on-year growth in revenue. These metrics will be crucial in determining the stock's future direction and the company's standing in its competitive sector.